Stock Institutional Ownership and Shareholders

SecurityMRNA / Marina Biotech, Inc. (56804Q201)
Interim CEORamelli Joseph W.
Institutional Owners1
Institutional Shares2
Outstanding Shares9,869,672 (as of 2017-09-30)

Marina Biotech, Inc. (OTC:MRNA) has 1 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2 shares. Largest shareholders include Regal Wealth Group, Inc..



Marina Biotech, Inc. (OTC:MRNA) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev Shares Current Shares Change
(Percent)
Prev Value (x$1000) Current Value (x$1000) Change
(Percent)
2017-10-24 13F-HR HUNTINGTON NATIONAL BANK 12,500 0 -100.00 5 0 -100.00
2017-08-17 13F-HR Regal Wealth Group, Inc. 2 2 0.00 0 0
2017-05-15 13F-HR/A-3 Pine River Capital Management L.P. 0 0 0 0
CUSIP: 56804Q201